Enhanced counseling for women undergoing BRCA1/2 testing: Impact on subsequent decision making about risk reduction behaviors

Health Education and Behavior

Volumn 32, Issue 5, 2005, Pages 654-667

  Miller, Suzanne M ^a   Roussi, Pagona ^b   Daly, Mary B ^a   Buzaglo, Joanne S ^a   Sherman, Kerry ^a   Godwin, Andrew K ^a   Balshem, Andrew ^a   Atchison, Margaret E ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

BRCA1 2 genetic risk; Enhanced counseling intervention; Prophylactic ovarian surgery

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPREHENSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HETEROZYGOTE; HUMAN; METHODOLOGY; OVARY TUMOR; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; TUMOR SUPPRESSOR GENE;

COMPREHENSION; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HUMANS; OVARIAN NEOPLASMS; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR;

EID: 26444551136     PISSN: 10901981     EISSN: None     Source Type: Journal    
DOI: 10.1177/1090198105278758     Document Type: Article

References (50)

1. Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. American Journal of Human Genetics, 72, 1117-1130.
2. Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., et al. (2003). Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics, 118A, 201-209.
3. Braithwaite, D., Emery, J., Walter, F., Prevast, A. T., & Sutton, S. (2004). Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. Journal of the National Cancer Institute, 96 (2), 122-133.
4. Brehaut, J. C., O'Connor, A. M., Wood, T. J., Hack, T. F., Siminoff, L., Gordon, E., et al. (2003). Validation of a Decision Regret Scale. Medical Decision Making, 23(4), 281-292.
5. Daly, M. (1999). NCCN practice guidelines: Genetics/familial high-risk cancer screening. Oncology, 13(11A), 161-183.
6. Degner, L. F., Kristjanson, L. J., Bowman, D., Sloan, J. A., Carriere, K. C., O'Neil, J., et al. (1997). Information needs and decisional preferences in women with breast cancer. Journal of the American Medical Association, 277(18), 1485-1492.
7. Easton, D. F., Ford, D., & Bishop, D. T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium. American Journal of Human Genetics, 56, 265-271.
8. Green, M. J., Peterson, S. K., Wagner Baker, M., Harper, G. R., Friedman, L. C., Rubinstein, W. S., et al. (2004). Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility. Journal of the American Medical Association, 292 (4), 442-452.
9. Hallowell, N. (1998). "You don't want to lose your ovaries because you think 'I might become a man.'" Women's perceptions of prophylactic surgery as a cancer risk management option. Psychooncology, 7(3), 263-275.
10. Hallowell, N., Foster, C., Ardern-Jones, A., Eeles, R., Murday, V., & Watson, M. (2002). Genetic testing for women previously diagnosed with breast/ovarian cancer: Examining the impact of BRCA1 and BRCA2 mutation searching. Genetic Testing, 6(2), 79-87.
11. Hallowell, N., & Richards, M. P. M. (1997). Understanding life's lottery: An evaluation of studies of genetic risk awareness. Journal of Health Psychology, 21, 31-43.
12. Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of Events Scale: A measure of subjective stress. Psychosomatic Medicine, 41(3), 209-218.
13. Hurley, K. E., Miller, S. M., Costalas, J. W., Gillespie, D., & Daly, M. B. (2001). Anxiety/uncertainty as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. Journal of Women's Health & Gender-Based Medicine, 10, 189-199.
14. Isaacs, C., Peshkin, B. N., Schwartz, M., DeMarco, T. A., Main, D., & Lerman, C. (2002). Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Research and Treatment, 71, 103-112.
15. Janis, I. (1967). Effects of fear arousal on attitude change: Recent developments in theory and experimental research. In L. Berkowitz (Ed.), Advances in experimental social psychology (Vol. 3., pp. 166-224). New York: Academic Press.
16. Janis, I., & Leventhal, H. (1967). Human reactions to stress. In E. Borgatta & W. Lambert (Eds.), Handbook of personality theory and research (pp. 1041-1085). Chicago: Rand McNally.
17. Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., et al. (2002). Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of Medicine, 346, 1609-1615.
18. King, E. S., Rimer, B. K., Trock, B., Balshem, A., & Engstrom, P. (1990). How valid are mammography self-reports? American Journal of Public Health, 80, 386-388.
19. Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 1, 75-80.
20. Leventhal, H., & Patrick-Miller, L. (2000). Emotions and physical illness: Causes and indicators of vulnerability. In M. Lewis & J. Haviland (Eds.), Handbook of emotions (pp. 523-537). New York: Plenum.
21. Loewenstein, G. (2005). Projection bias in medical decision making. Medical Decision Making, 25(1), 96-105.
22. Loewenstein, G. F., Weber, E. U., Hsee, C. K., & Welch, N. (2001). Risk as feelings. Psychological Bulletin, 127(2), 267-286.
23. Marteau, T. M., & Lerman, C. (2001). Genetic risk and behavioral change. BMJ, 322, 1056-1059.
24. McInerney-Leo, A., Biesecker, B. B., Hadley, D. W., Kase, R. G., Giambarresi, T. R., Johnson, E., et al. (2004). BRCA1/2 testing in hereditary breast and ovarian cancer families: Effectiveness of problem-solving training as a counseling intervention. American Journal of Medical Genetics Part A, 130(3), 221-227.
25. Meijers-Heijboer, H., Brekelmans, C. T. M., Menke-Pluymers, M., Seynaeve, C., Baalbergen, A., Burger, C., et al. (2003). Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology, 21, 1675-1681.
26. Meijers-Heijboer, H., Verhoog, L. C., Brekelmans, C. T. M., Seynaeve, C., Tilanus-Linthorst, M. M. A., Wagner, A., et al. (2000). Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet, 355, 2015-2020.
27. Meiser B., Tiller K., Gleeson M. A., Andrews L., Robertson G., & Tucker K. M. (2000). Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer. Psychooncology, 9, 496-503.
28. Miller, S. M., Fang, C. Y., Manne, S. L., Engstrom, P. E., & Daly, M. B. (1999). Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecologic Oncology, 75, 406-412.
29. Miller, S. M., Shoda, Y., & Hurley, K. (1996). Applying cognitive-social theory to health protective behavior: Breast self-examination in cancer screening. Psychological Bulletin, 119, 70-94.
30. National Institutes of Health Consensus Conference. (1995). Ovarian cancer: Screening, treatment, and follow-up. Journal of the American Medical Association, 273, 491-497.
31. O'Connor, A. M. (1995). Validation of a Decisional Conflict Scale. Medical Decision Making, 15(1), 25-30.
32. O'Connor, A. M., Fiset, V., DeGrasse, C., Graham, I. D., Evans, W., Stacey, D., et al. (1999). Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications. Journal of the National Cancer Institute Monographs, 25, 67-80.
33. O'Connor, A. M., Jacobsen, M. J., & Stacey, D. (2002). An evidence-based approach to managing women's decisional conflict. Journal of Obstetric, Gynecologic, and Neonatal Nursing Online, 31, 570-581.
34. Patenaude, A. F. (2005). Genetic testing for cancer: Psychological approaches for helping patients and families. Washington, DC: American Medical Association.
35. Peshkin, B. N., DeMarco, T. A., Brogan, B. M., Lerman, C., & Isaacs, C. (2001). BRCA1/2 testing: Complex themes in result interpretation. Journal of Clinical Oncology, 19, 2555-2565.
36. Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., et al. (1999). Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Journal of the National Cancer Institute, 91, 1475-1479.
37. Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., et al. (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. New England Journal of Medicine, 346(21), 1616-1622.
38. Rothbaum, B. O., Kozak, M. J., Foa, E. B., & Whitaker, D. J. (2001). Posttraumatic stress disorder in rape victims: Autonomic habituation to auditory stimuli. Journal of Traumatic Stress, 14(2), 283-293.
39. Scheuer L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology, 20, 1260-1268.
40. Schrag, D., Kuntz, K. M., Garber, J. E., & Weeks, J. C. (1997). Decision analysis - Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. New England Journal of Medicine, 336(20), 1465-1471.
41. Schwartz, M. D., Kaufman, E., Peshkin, B. N., Isaacs, C., Hughes, C., DeMarco, T., et al. (2003). Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. Journal of Clinical Oncology, 21, 4034-4041.
42. Schwartz, M. D., Lerman, C., Miller, S. M., Daly, M., & Masny, A. (1995). Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychology, 14(3), 232-235.
43. Shoda, Y., Mischel, W., Miller, S., Diefenbach, M., Daly, M. B., & Engstrom, P. F. (1998). Psychological interventions and genetic testing: Facilitating informed decisions about BRCA1/2 cancer susceptibility. Journal of Clinical Psychology in Medical Settings, 5, 3-17.
44. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. (1983). State-Trait Anxiety Inventory for adults: Sampler set - Manual, test, scoring key. Palo Alto, CA: Mind Garden.
45. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336, 1401-1408.
46. Tinley, S. T., Houfek, J., Watson, P., Wenzel, L., Clark, M. B., Coughlin, S., et al. (2004). Screening adherence in BRCA1/2 families is associated with primary physician's behavior. American Journal of Medical Genetics, 125A, 5-11.
47. Ubel, P. A. (2005). Emotions, decisions, and the limits of rationality: Symposium introduction. Medical Decision Making, 25(1), 95-96.
48. van Roosmalen, M. S., Stalmeier, P. F. M., Verhoef, L. C. G., Hoekstra-Weebers, J. E. H. M., Oosterwijk, J. C., Hoogerbrugge, N., et al. (2004). Randomised trial of decision aid and its timing for women being tested for a BRCA1/2 mutation. British Journal of Cancer, 90, 333-342.
49. Wang, C. W., Gonzalez, R., & Merajver, S. D. (2004). Assessment of genetic testing and related counseling services: Current research and future directions. Social Science & Medicine, 58(7), 1427-1442.
50. Whittemore, A. S., Gong, G., & Intyre, J. (1997). Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case control studies of ovarian cancer. American Journal of Human Genetics, 60, 496-504.